Logo Image
|Articles|November 25, 2014

Special Reports

  • Immunotherapy (Issue 4)
  • Volume 4
  • Issue 1

Potential Immunotherapies for Head and Neck Cancers

Barbara Burtness, MD, discusses potential immunotherapy agents that may assist in the treatment of head and neck cancers.

Barbara Burtness, MD, Clinical Research Program Leader, Head and Neck Cancers Program,Co-Director, Developmental Therapeutics Research Program,Professor of Medicine (Medical Oncology), Yale Cancer Center, discusses potential immunotherapy agents that may assist in the treatment of head and neck cancers.

<<<

Articles in this issue

almost 12 years ago

To Combine or Sequence Anti-PD-1 and Anti-PD-L1 in Question

almost 12 years ago

Programs Prepare for Immuno-Oncology in Clinical Setting

almost 12 years ago

Right Patient for Immunotherapy in NSCLC Explored

almost 12 years ago

Weight May Affect Toxicity of Immunotherapies

almost 12 years ago

Adverse Events Associated With Immunotherapy in Lung Cancer

almost 12 years ago

Immunotherapy Potential Option in Mesothelioma Treatment

almost 12 years ago

Immunotherapies for Prostate Cancer

Related to this article

View more